Cancer prevention: Past, present, future

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 402, Issue 1-2, 1998, Pages 7-14

  Sugimura, Takashi ^a  

^a NATIONAL CANCER CENTER   (Japan)

Author keywords

Genomic instability; Multiple carcinogenic factor; Multiple genetic alteration; Multistep carcinogenesis; Prevention

Indexed keywords

CANCER; CANCER PREVENTION; CARCINOGENESIS; CONFERENCE PAPER; GENETIC STABILITY; GENOME; HUMAN; NONHUMAN; PRIORITY JOURNAL;

ANTICARCINOGENIC AGENTS; HUMANS; MUTATION; NEOPLASMS; SMOKING CESSATION;

EID: 0032543394     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(97)00276-5     Document Type: Conference Paper

References (56)

1. [1] C.H. Hennekens, J.E. Buring, Epidemiology in Medicine, Little Brown, Boston, 1987.
2. [2] M.B. Shimkin, Contrary to Nature, US Department of Health, Education and Welfare, Public Health Service, National Institutes of Health, Washington, DC, 1977.
3. [3] P. Greenwald, B.S. Kramer, D.L. Weed (Eds.), Cancer Prevention and Control, Marcel Dekker, New York, 1995.
4. [4] E.R. Fearon, B. Vogelstein, A genetic model for colorectal tumorigenesis, Cell 61 (1990) 759-767.
5. [5] T. Sugimura, Multistep carcinogenesis: a 1992 perspective, Science 258 (1992) 603-607.
6. [6] T. Sugimura, M. Terada, J. Yokota, S. Hirohashi, K. Wakabayashi, Multiple genetic alterations in human carcinogenesis, Environ. Health Perspect. 98 (1992) 5-12.
7. [7] I.C. Hsu, R.A. Metcalf, T. Sun, J.A. Welsh, N.J. Wang, C.C. Harris, Mutational hotspot in the p53 gene in human hepatocellular carcinomas, Nature 350 (1991) 427-428.
8. [8] B. Bressac, M. Kew, J. Wands, M. Ozturk, Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa, Nature 350 (1991) 429-431.
9. [9] J.S. Felton, M.G. Knize, N.H. Shen, P.R. Lewis, B.D. Andresen, J. Happe, F.T. Hatch, The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis 7 (1986) 1081-1086.
10. [10] N. Ito, R. Hasegawa, M. Sano, S. Tamano, H. Esumi, S. Takayama, T. Sugimura, A new colon and mammary carcinogen in cooked food, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), Carcinogenesis 12 (1991) 1503-1506.
11. [11] M. Jägerstad, K. Skog, S. Grivas, K. Olsson, Formation of heterocyclic amines using model systems, Mutat. Res. 259 (1991) 219-233.
12. [12] R. Kato, Y. Yamazoe, Metabolic activation and covalent binding to nucleic acids of carcinogenic heterocyclic amines from cooked foods and amino acid pyrolysates, Gann 78 (1987) 297-311.
13. 3450 and P450a, Mol. Carcinog. 1 (1989) 253-259.
14. [14] H. Kakiuchi, M. Watanabe, T. Ushijima, M. Toyota, K. Imai, J.H. Weisburger, T. Sugimura, M. Nagao, Specific 5′-GGGA-3′ → 5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 910-914.
15. [15] F. Canzian, T. Ushijima, T. Serikawa, K. Wakabayashi, T. Sugimura, M. Nagao, Instability of microsatellites in rat colon tumors induced by heterocyclic amines, Cancer Res. 54 (1994) 6315-6317.
16. [16] H.-J. Han, A. Yanagisawa, Y. Kato, J.-G. Park, Y. Nakamura, Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer, Cancer Res. 53 (1993) 5087-5089.
17. [17] S.J. Meltzer, J. Yin, B. Manin, M.-G. Rhyu, J. Cottrell, E. Hudson, J.L. Redd, M.J. Krasna, J.M. Abraham, B.J. Reid, Microsatellite instability occurs frequently and in both diploid and aneuploid cell populations of Barrett's-associated esophageal adenocarcinomas, Cancer Res. 54 (1994) 3379-3382.
18. [18] H. Kasai, S. Nishimura, Hydroxylation of guanine in nucleosides and DNA at the C-8 position by heated glucose and oxygen radical-forming agents, Environ. Health Perspect. 67 (1986) 111-116.
19. [19] J.A. Imlay, S. Linn, DNA damage and oxygen radical toxicity, Science 240 (1988) 1302-1309.
20. [20] D.A. Wink, K.S. Kasprzak, C.M. Maragos, R.K. Elespuru, M. Misra, T.M. Dunams, T.A. Cebula, W.H. Koch, A.W. Andrews, J.S. Allen, L.K. Keefer, DNA deaminating ability and genotoxicity of nitric oxide and its progenitors, Science 254 (1991) 1001-1003.
21. [21] T. Oda, Y. Kanai, T. Oyama, K. Yoshiura, Y. Shimoyama, W. Birchmeier, T. Sugimura, S. Hirohashi, E-Cadherin gene mutations in human gastric carcinoma cell lines, Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 1858-1862.
22. [22] K. Yoshiura, Y. Kanai, A. Ochiai, Y. Shimoyama, T. Sugimura, S. Hirohashi, Silencing of the E-cadherin invasion-suppressor gene by CpG methylation in human carcinomas, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 7416-7419.
23. [23] M. Perucho, Microsatellite instability: the mutator that mutates the other mutator, Nat. Med. 2 (1996) 630-631.
24. [24] H.-J. Man, A. Yanagisawa, Y. Kato, J.-G. Park, Y. Nakamura, Genetic instability in pancreatic cancer and poorly differentiated type of gastric cancer, Cancer Res. 53 (1993) 5087-5089.
25. [25] D. Shibata, M.A. Peinado, Y. Ionov, S. Malkhosyan, M. Perucho, Genomic instability in repeated sequences is an early somatic event in colorectal tumorigenesis that persists after transformation, Nat. Genet. 6 (1994) 273-281.
26. [26] G. Marra, C.R. Boland, Hereditary nonpolyposis colorectal cancer (HNPCC): the syndrome, the genes, and historical perspectives, J. Natl. Cancer Inst. 87 (1995) 1114-1125.
27. [27] A.M. Pamukcu, Investigations on the pathology of enzootic bovine hematuria in Turkey, Zentralbl. Vet. Med. 2 (1955) 409-429.
28. [28] I.A. Evans, J. Mason, Carcinogenic activity of bracken, Nature 208 (1965) 913-914.
29. [29] I. Hirono, C. Shibuya, K. Fushimi, M. Haga, Studies on carcinogenic properties of bracken Pteridium aquilinum, J. Natl. Cancer Inst. 45 (1970) 179-188.
30. [30] J.C.M. van der Hoeven, W.J. Lagerweij, M.A. Posthumus, A. van Veldhuizen, H.A.J. Holterman, Aquilide A, a new mutagenic compound isolated from bracken fern (Pteridium aquilinum (L.) Kuhn), Carcinogenesis 4 (1983) 1587-1590.
31. [31] I. Hirono, S. Aiso, T. Yamaji, H. Mori, K. Yamada, H. Niwa, M. Ojika, K. Wakamatsu, H. Kigoshi, K. Niiyama, Y. Uosaki, Carcinogenicity in rats of ptaquiloside isolated from bracken, Gann 75 (1984) 833-836.
32. [32] D.P. Slaughter, H.W. Southwick, W. Smejkal, Field cancerization in oral stratified squamous epithelium: clinical implications of multicentric origin, Cancer 6 (1953) 963-968.
33. [33] Y. Kobayashi, H. Arimoto, S. Watanabe, Occurrence of multiple primary cancer at the National Cancer Center Hospital, 1962-1989, Jpn. J. Clin. Oncol. 21 (1991) 233-251.
34. [34] T. Sugimura, An overview of cancer prevention, Eur. J. Cancer Prev. 5 (2) (1996) 1-8.
35. [35] M.P. Coleman, J. Esteve, P. Damiecki, A. Arslan, H. Renard, Trends in cancer incidence and mortality, IARC Scientific Publications No. 121, International Agency for Research on Cancer, Lyon, 1993.
36. [36] M. Takahashi, M. Fukutake, T. Isoi, K. Fukuda, H. Sato, K. Yazawa, T. Sugimura, K. Wakabayashi, Suppression of azoxymethane-induced rat colon carcinoma development by a fish oil component, docosahexaenoic acid (DHA), Carcinogenesis 18 (1997) 1337-1342.
37. [37] T. Tahira, H. Ohgaki, K. Wakabayashi, M. Nagao, T. Sugimura, The inhibitory effect of thioproline on carcinogenesis induced by N-benzylmethylamine and nitrite, Food Chem. Toxicol. 26 (1988) 511-516.
38. [38] M.J. Thun, M.M. Namboodiri, C.W. Heath Jr., Aspirin use and reduced risk of fatal colon cancer, N. Engl. J. Med. 325 (1991) 1593-1596.
39. [39] D. Labyle, D. Fischer, P. Vielh, F. Drouhin, A. Pariente, C. Bories, O. Duhamel, M. Trousset, P. Attali, Sulindac causes regression of rectal polyps in familial adenomatous polyposis, Gastroenterology 101 (1991) 635-639.
40. [40] B.S. Reddy, K. Tokumo, N. Kulkarni, C. Aligia, G. Kelloff, Inhibition of colon carcinogenesis by prostaglandin synthesis inhibitors and related compounds, Carcinogenesis 13 (1992) 1019-1023.
41. [41] B.S. Reddy, C.V. Rao, A. Rivenson, G. Kelloff, Inhibitory effect of aspirin on azoxymethane-induced colon carcinogenesis in F344 rats, Carcinogenesis 14 (1993) 1493-1497.
42. [42] M. Takahashi, M. Fukutake, S. Yokota, K. Ishida, K. Wakabayashi, T. Sugimura, Suppression of azoxymethane-induced aberrant crypt foci in rat colon by nimesulide, a selective inhibitor of cyclooxygenase 2, J. Cancer Res. Clin. Oncol. 122 (1996) 219-222.
43. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2), Cell 87 (1996) 803-809.
44. [44] Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group, The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in smokers, N. Engl. J. Med. 330 (1994) 1029-1035.
45. [45] G.S. Omenn, G.E. Goodman, M.D. Thornquist, J. Balmes, M.R. Cullen, A. Glass, J.P. Keogh, F.L. Meyskens Jr., B. Valanis, J.H. Williams Jr., S. Barnhart, S. Hammar, Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease, N. Engl. J. Med. 334 (1996) 1150-1155.
46. [46] Y. Kuroda, Antimutagenesis studies in Japan, in: Y. Kuroda, D.M. Shankel, M.D. Waters (Eds.), Antimutagenesis and Anticarcinogenesis Mechanisms II, Plenum, New York, 1990, pp. 1-22.
47. [47] K.J. Rothman, Causes, Am. J. Epidemiol. 104 (1976) 587-592.
48. [48] D. Kritchevsky, M.M. Weber, D.M. Klurfeld, Dietary fat versus caloric content in initiation and promotion of 7,12-dimethylbenz(a)anthracene-induced mammary tumorigenesis in rats, Cancer Res. 44 (1984) 3174-3177.
49. [49] M.M. Mathews-Roth, Antitumor activity of β-carotene, canthaxanthin and phytoene, Oncology 39 (1982) 33-37.
50. [50] Y. Satomi, T. Yoshida, K. Aoki, N. Misawa, M. Masuda, M. Murakoshi, N. Takasuka, T. Sugimura, H. Nishino, Production of phytoene, an oxidative stress protective carotenoid, in mammalian cells by introduction of phytoene synthase gene crtB isolated from a bacterium Erwinia uredovora, Proc. Jpn. Acad. Ser. B 71 (1995) 236-240.
51. [51] I.B. Weinstein, Nakahara memorial lecture: cyclins, disordered cell circuitry and cancer prevention, in Extended Abstracts for the 27th International Symposium of the Princess Takamatsu Cancer Research Fund, November 12-14, 1996, Tokyo, Japan, 1997, pp. 76-79.
52. [52] H.L. Chen, M.H. Chang, Y.H. Ni, H.Y. Hsu, P.I. Lee, C.Y. Lee, D.S. Chen, Seroepidemiology of hepatitis B virus infection in children: ten years of mass vaccination in Taiwan, JAMA 276 (1996) 906-908.
53. [53] M.H. Chang, C.J. Chen, M.S. Lai, H.M. Hsu, T.C. Wu, M.S. Kong, D.C. Liang, W.Y. Shau, D.S. Chen, Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children, N. Engl. J. Med. 336 (1997) 1855-1859.
54. [54] S. Takano, K. Nakamura, S. Kawai, O. Yokosuka, Y. Satomura, M. Omata, Prospective assessment of donor blood screening for antibody to hepatitis C virus by first-and second-generation assays as a means of preventing post-transfusion hepatitis, Hepatology 23 (1996) 708-712.
55. [55] K. Tajima, HTLV-I/II related disease with special reference to its distribution among mongoloids, Gann Monogr. Cancer Res. 44 (1996) 123-133.
56. [56] D.I. Feig, T.M. Reid, L.A. Loeb, Reactive oxygen species in tumorigenesis, Cancer Res. 54 (1994) 1890s-1894s.